Department of Anesthesia, University Children's Hospital Zurich, Zurich, Switzerland.
Department of Anesthesiology, RWTH Aachen University Hospital, Aachen, Germany.
Paediatr Anaesth. 2021 Apr;31(4):474-481. doi: 10.1111/pan.14123. Epub 2021 Feb 11.
Balloon-tipped bronchial blocker catheters are widely used in pediatric thoracic anesthesia to establish single-lung ventilation. In clinical practice, their balloons demonstrate sudden expansion when inflated with air. In addition, there are concerns related to the high inflation pressures required to expand the balloons.
This in vitro study assessed inflation volume- and inflation pressure-balloon diameter characteristics of the Fogarty arterial embolectomy catheters and Arndt endobronchial blockers. Balloon diameters were photographically assessed during unrestricted volume- and pressure-guided inflation, using air up to the maximum allowed inflation volume as indicated by the manufacturers. Inflation pressures required to open the blocker balloons and inflation pressures needed to expand them to maximum indicated diameter were measured.
Volume-guided inflation demonstrated a late acute rise in diameter in Fogarty blocker balloons, whereas in the Arndt endobronchial blocker balloons almost linear inflation volume-to-diameter characteristics were observed. Pressure-guided inflation on the other hand demonstrated low-volume, high-pressure characteristics in the Fogarty blocker balloons, with inflation pressures required to expand the balloons to maximum diameters ranging from (mean (SD)) 636 (75) to 947 (152) cmH O. The inflation pressures required to open the Fogarty blocker balloons were even >1000 cmH O. Inflation pressures required to expand the 5 F, 7 F, and 9 F Arndt endobronchial blocker balloons to maximum indicated diameter were much lower, namely at 218 (15), 252 (28), and 163 (8) cmH O.
Based on these study findings, the balloons of Fogarty arterial embolectomy catheters represent high-pressure devices and do not permit stepwise controlled bronchial blockage. The Arndt endobronchial blockers have some advantages over the Fogarty blocker devices, but also represent high-pressure equipment and must be used with caution and limited duration. Manufacturers are asked to design pediatric endobronchial blocker catheters with truly high-volume, low-pressure balloons in accordance to age-related pediatric airway dimensions.
球囊尖端支气管阻塞导管广泛应用于小儿胸科麻醉以建立单肺通气。在临床实践中,当用空气充气时,它们的球囊会突然膨胀。此外,人们还担心为了使球囊膨胀而需要高充气压力。
本体外研究评估了 Fogarty 动脉取栓导管和 Arndt 支气管内阻塞器的充气体积-和充气压力-球囊直径特征。使用制造商规定的空气直至最大允许充气体积,在不受限制的体积-和压力引导充气过程中,通过摄影评估球囊直径。测量打开阻塞器球囊所需的充气压力和将其膨胀至最大指示直径所需的充气压力。
体积引导充气显示 Fogarty 阻塞器球囊的直径呈晚期急性上升,而在 Arndt 支气管内阻塞器球囊中则观察到几乎呈线性的充气体积-直径特征。另一方面,压力引导充气在 Fogarty 阻塞器球囊中显示出低体积、高压力特征,将球囊膨胀至最大直径所需的充气压力范围为(平均值(标准差))636(75)至 947(152)cmH2O。将 Fogarty 阻塞器球囊膨胀至最大直径所需的充气压力甚至超过 1000 cmH2O。将 5 F、7 F 和 9 F 的 Arndt 支气管内阻塞器球囊膨胀至最大指示直径所需的充气压力要低得多,分别为 218(15)、252(28)和 163(8)cmH2O。
根据这些研究结果,Fogarty 动脉取栓导管的球囊代表高压设备,不允许逐步控制支气管阻塞。Arndt 支气管内阻塞器相对于 Fogarty 阻塞器装置具有一些优势,但也代表高压设备,必须谨慎使用且使用时间有限。制造商被要求根据与年龄相关的小儿气道尺寸,为小儿支气管内阻塞器导管设计真正具有大体积、低压力的球囊。